Quirante, Ginalyn .

HRN: 24-42-05  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/24/2025
05/25/2025
IV
500 Mg
Q8h X 8 Doses
Sp D&C
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: